openPR Logo
Press release

Stroke Disorder and Treatment Market 2019 Key Country Analysis: AstraZeneca, Pfizer, Bayer Pharma AG, Daiichi Sankyo, Novartis AG and other

02-15-2019 04:34 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Stroke Disorder & Treatment Market

Stroke Disorder & Treatment Market

Market Scenario

The Global Stroke Disorder And Treatment Market is presumed to demonstrate a healthy CAGR during the forecast period (2016-2022) owing to the rising high blood pressure patients, asserts Market Research Future (MRFR). Stroke is referred to as the condition which occurs when clot is formed in the artery and oxygen supply is cut off. Brain cells thus get deprived of oxygen and start to die. Heart and brain strokes can strike any moment and can be fatal. Stroke is considered as one of the leading causes of death across the world with higher prevalence in the geriatric population.

Get Sample Copy @

Drivers and Constraints Impacting the Market

With increasing consumption of alcohol and diabetic patients, the global stroke disorder and treatment market is likely to flourish. Also, the increasing prevalence of cardiovascular diseases is highly influencing the market across the globe. Brain problems and heart problems are considered as the most dangerous medical issues across the world with expensive medication and treatments. Thus, the market offering treatment for it is lucrative. The market is further accelerated by the huge patient pool along with rising geriatric population across the globe. Moreover, atrial fibrillation, hypertension, and coronary heart diseases are contributing to the growth of the market.

On the flip side, high cost of treatment adversely affects the growth of the market. Moreover, the lack of transparent reimbursement scenario is also likely to dampen the stroke disorder and treatment market during the assessment period.

Global Stroke Disorder and Treatment Market: Segmental Analysis

The global stroke disorder and treatment market has been segmented on the basis of type, medicine, treatment, and region.

By mode of type, the global stroke disorder and treatment market has been segmented into ischemic stroke and hemorrhagic strokes. Among these, the weakened blood vessel leakage is referred to as hemorrhagic stroke. Ischemic stroke generally occurs due to an obstruction within a blood vessel which supplies blood to the brain.

By mode of medicine, the global stroke disorder and treatment market has been segmented into anticoagulants/antiplatelet, anti-hypertensive.

By mode of treatment, the global stroke disorder and treatment market has been segmented into tissue plasminogen activator (TPA), carotid endarterectomy, surgical treatment, endovascular procedures, and others. TPA is referred to as an enzyme involved in the breakdown of blood clots and dissolves them. It is a less invasive procedure and is used for treating problems affecting the blood vessels like aneurysm.

Competitive Dashboard

The prominent players operating the global stroke disorder and treatment market are AstraZeneca (U.K), Bayer Pharma AG (Germany), Novartis AG (Switzerland), Daiichi Sankyo (Japan), and Pfizer (U.S).

Regional Insights

Geographically, the stroke disorder and treatment market span across regions namely, Europe, North America, Asia Pacific, and Rest-of-the-World.

Among these, the North America region is presumed to dominate the stroke diagnostics and therapeutics market and is likely to maintain its dominance. The growth is attributed to the rising awareness among the population regarding the symptoms of stroke followed by the several harmful effects associated with high glucose level in blood. With technological advancements and high-end research, and rising public interest, the demand for stroke disorder and treatment is likely to trigger in the coming years. Moreover, encouraging healthcare infrastructure and higher healthcare expenditure are some of the major factors contributing to the growth of the stroke disorder and treatment market.

European holds the second-largest position with high diabetic population. Moreover, the growing percentage of diabetes mellitus population is directly proportionate to the associated risk of stroke in individuals, thereby contributing to the market growth during the assessment period. Additionally, technological advancements and healthcare research are further influencing the market growth.

Industry Updates

CERENOVUS business has recently launched the single largest global registry, the EXCELLENT Registry, in order to collect and analyze stroke-inducing blood clots removed from the brain with its EMBOTRAP II Revascularization Device. The EXCELLENT Registry is likely to enroll up to 1000 ischemic stroke patients in as many as 50 clinical sites in Europe and the United States.

Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stroke Disorder and Treatment Market 2019 Key Country Analysis: AstraZeneca, Pfizer, Bayer Pharma AG, Daiichi Sankyo, Novartis AG and other here

News-ID: 1592962 • Views: 322

More Releases from Market Research Future

Clinical Trial Management System Market Demand, Industry Share, Size, Applicatio …
Clinical Trial Management System Market Analysis by Type (Enterprise Clinical Trial Management System), Delivery Model (Licensed Enterprise), Component (Service) and End-User (Medical Device Manufacturers), and Regional Competitive Share, Size and Trends, 2018-2023 Market Overview Clinical Trial Management System Market is mostly a software system which helps to plan, prepare, and manage a large amount of clinical trials data that is produced by biotechnological and pharmaceutical companies. Drug research has gained momentum in
Reusable Satellite Launch Vehicle (RSLV) Market 2019-2023 | Report Information b …
Global Reusable Satellite Launch Vehicle Market Report Information by Configuration (Single Stage, Multiple Stage), by Type (Partially Reusable, Fully Reusable), Vehicle Weight (Up to 4,000lbs, 4000-9000lbs, Over 9000lbs), & by Region - Forecast Till 2023 The Reusable satellite launch vehicle market is estimated to witness a CAGR of more than 12% during the forecast period from 2018 to 2023. The key players in the reusable satellite launch vehicle market are Airbus S.A.S
Bakery Enzymes Market Global Research Report and Top Key Players: AB Enzymes Gmb …
Market Overview The increasing demand for bakery products in the food and beverage industry including, bread, cookies, and pastries are raising the demand for bakery enzymes at a global level. Enzymes are an important ingredient used in most bakery products. There are two scenarios regarding the use of enzymes, either the enzymes are used to convert the raw material into the main product, or the enzymes are used as additives to
Commercial Airport Lighting Market 2019-2023 | Worldwide Overview By Technology, …
Global Commercial Airport Lighting Market Research Report: Information by Technology (LED, Non-LED), by Application (Airside Lighting, Terminal Lighting, Landside Lighting), and by Region — Forecast till 2023 Honeywell International Inc., (US), ADB SAFEGATE (US), ABB (Switzerland), vosla GmBH (Germany), Avlite (Australia), Carmanah (Canada), Eaton (Ireland), atg airports limited (UK), Avionics Group (US), and HELLA GmBH & Co. KGaA (Germany) are some of the prominent players profiled in MRFR Analysis and are

All 5 Releases

More Releases for Stroke

Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Telemedicine Market - The Rising Number of Stroke
The global telemedicine market is anticipated to demonstrate promising growth in the coming years, according to a report published by Transparency Market Research (TMR). The market is characterized with the presence of a number of small and large players, and features a highly competitive environment. The leading vendors operating in the global telemedicine market are CISCO Systems, Inc., McKesson Corporation, Polycom Corp., and AMD Global Telemedicine. Vendors are expected to
7th International Conference on Neurological Disorders & Stroke
Greetings from Stroke Congress 2018!! We are writing to request all your presence to our CME accredited event as our eminent Speaker for the upcoming “7th International Conference on Neurological Disorders & Stroke (Stroke Congress 2018)” scheduled to be held on September 20-21, 2018 in Rome, Italy. The theme of the conference is Melioration in Innovations with advancement in Neurological disorders and Stroke to create awareness on the current needs &
Stroke Management Market By Application Ischemic Stroke and Hemorrhagic Stroke
The advancements in technology and facilities to diagnose stroke and discovery of novel drugs will drive growth of stroke management market. Technologies such as robotic-assisted angiography or exoskeleton soft suit for rehabilitation are the upcoming future of stroke management market. Moreover, an idea of Mobile Stroke Treatment Units (MSTU) was introduced in Germany in 2003 and was used in Berlin for the first time in 2008. The Prehospital Acute Neurological
Intracranial Stents Sales In Global Market, 2017: By Product Types - Ischemic St …
Researchmoz added Most up-to-date research on "Intracranial Stents Sales In Global Market, 2017: By Product Types - Ischemic Stroke & Hemorrhagic Stroke" to its huge collection of research reports. This report studies sales (consumption) of Intracranial Stents in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Medtronic Stryker MicroVention?Terumo? Abbott Balt Boston Scientific Obex Medical DePuy
Rising prevalence of ischemia stroke cases in Asia-Pacific Acute Ischemic Stroke …
“Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market" research report published by Market Data Forecast estimates that the market is growing with a CAGR of 7.9% to reach USD 507.758 million by 2021, from USD 356.726 million in 2016, which amounts to a cumulative growth of USD 151.03 million. Acute ischemic strokes imply the loss of brain function in certain parts created by the lack of blood supply to the brain.